Trademark Overview
On Friday, June 26, 2026, a trademark application was filed for ELIMCV with the United States Patent and Trademark Office. The USPTO has given the ELIMCV trademark a serial number of 99907873. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 26, 2026. This trademark is owned by Staidson (Beijing) Biopharmaceuticals Co., Ltd.. The ELIMCV trademark is filed in the Pharmaceutical Products category with the following description:
Medicines for human purposes for the treatment of disease of respiratory system, acute respiratory distress syndrome, ANCA-associated vasculitis, Corona Virus Disease 2019, autoimmune disorders, inflammatory response syndrome (SIRS), sepsis, septic shock, ischemia/reperfusion related injuries, acute lung injury, pneumonia, acute and chronic graft rejection in transplant patients, graft versus host reactions, renal glomerular diseases, glomerulonephritis, entities of renal failure, rheumatoid arthritis, auto-immune diseases, Bechterew's disease, lupus-type diseases, inflammatory bowel disease, Crohn's disease, tumor growth, and solid organ cancer; pharmaceutical preparations for the treatment of disease of respiratory system; Diagnostic preparations for medical purposes; dietetic foods and beverages adapted for medical use; depuratives for the body; veterinary pharmaceutical compounds for the treatment of respiratory system disease; Pesticides; first aid kits; Dental abrasives
